BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18204739)

  • 1. Cloning and purification of functionally active Fas ligand interfering protein (FIP) expressed in Escherichia coli.
    Wisniewski P; Master A; Kaminska B
    Acta Biochim Pol; 2008; 55(1):51-6. PubMed ID: 18204739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Lin Z; Lei H; Cao P
    Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refolding of the Cupressus arizonica major pollen allergen Cup a1.02 overexpressed in Escherichia coli.
    Rea G; Iacovacci P; Ferrante P; Zelli M; Brunetto B; Lamba D; Boffi A; Pini C; Federico R
    Protein Expr Purif; 2004 Oct; 37(2):419-25. PubMed ID: 15358365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
    Richter W; Hermsdorf T; Kronbach T; Dettmer D
    Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
    Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
    Jin H; Uddin MS; Huang YL; Teo WK
    J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression and application of human Fas ligand in E.coli].
    Li NL; Nie H; Yu QW; Bo J; Ma AL; Zhang JY; Shen BH; Wang L; Zhang DQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):20-2. PubMed ID: 15132896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
    Cao P; Mei JJ; Diao ZY; Zhang Sq
    Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refolding and purification of yeast carboxypeptidase Y expressed as inclusion bodies in Escherichia coli.
    Hahm MS; Chung BH
    Protein Expr Purif; 2001 Jun; 22(1):101-7. PubMed ID: 11388806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies.
    Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I
    Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-column refolding and purification of transglutaminase from Streptomyces fradiae expressed as inclusion bodies in Escherichia coli.
    Liu XQ; Yang XQ; Xie FH; Song LY; Zhang GQ; Qian SJ
    Protein Expr Purif; 2007 Feb; 51(2):179-86. PubMed ID: 16935525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refolding and purification of rhNTA protein by chromatography.
    Fan X; Xu D; Lu B; Xia J; Wei D
    Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-column refolding purification and characterization of recombinant human interferon-lambda1 produced in Escherichia coli.
    Li M; Huang D
    Protein Expr Purif; 2007 May; 53(1):119-23. PubMed ID: 17194602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved secretion of human Fas ligand extracellular domain by N-terminal part truncation in Pichia pastoris and preparation of the N-linked carbohydrate chain trimmed derivative.
    Muraki M
    Protein Expr Purif; 2008 Aug; 60(2):205-13. PubMed ID: 18501631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification, refolding, and characterization of recombinant LHRH-T multimer.
    Raina K; Panda AK; Ali MM; Talwar GP
    Protein Expr Purif; 2004 Sep; 37(1):8-17. PubMed ID: 15294275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.
    Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z
    Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renaturation, purification and antigenicity identification of recombinant protein of Cysticercus cellulosae expressed in Escherichia coli].
    Zhang S; Jia W; Luo X; Jing Z; Wu G; Zheng Y; Guo A; Cai X
    Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1490-5. PubMed ID: 18998557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Wang D; Shi L
    Appl Biochem Biotechnol; 2009 Apr; 157(1):1-9. PubMed ID: 19306078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and in vitro folding of recombinant human thrombopoietin receptor expressed in Escherichia coli.
    Ng CK; Huxtable S; Xu P; Hsieh DP
    Protein Expr Purif; 2001 Feb; 21(1):129-33. PubMed ID: 11162397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and on-column refolding of EGFP overexpressed as inclusion bodies in Escherichia coli with expanded bed anion exchange chromatography.
    Cabanne C; Noubhani AM; Hocquellet A; Dole F; Dieryck W; Santarelli X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):23-7. PubMed ID: 15722040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.